AU Patent

AU2017364135B2 — Pharmaceutical parenteral formulation containing carglumic acid

Assigned to Recordati Industria Chimica e Farmaceutica SpA · Expires 2023-06-15 · 3y expired

What this patent protects

The present invention relates to a pharmaceutical formulation suitable for parenteral administration containing carglumic acid and a buffering agent having a pK

USPTO Abstract

The present invention relates to a pharmaceutical formulation suitable for parenteral administration containing carglumic acid and a buffering agent having a pK

Drugs covered by this patent

Cubicin (Daptomycin) · Baxter

Patent Metadata

Patent number: AU2017364135B2
Jurisdiction: AU
Classification: —
Expires: 2023-06-15
Drug substance claim: No
Drug product claim: No
Assignee: Recordati Industria Chimica e Farmaceutica SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.